This inventor holds 2 USPTO granted patents. Top assignee: Johns Hopkins University. Active years: 1998-1999.
Company Filing History:
Years Active: 1998-1999
Title: Jesse Roth: Innovator in Obesity and Diabetes Research
Introduction
Jesse Roth is a prominent inventor based in Baltimore, MD (US), known for her significant contributions to the fields of obesity and diabetes research. With a total of 2 patents, she has made strides in understanding the genetic factors that contribute to these prevalent health issues.
Latest Patents
Roth's latest patents include groundbreaking work on a polypeptide for obesity and type II diabetes mellitus. This invention provides a novel polypeptide characterized by a non-conservative missense mutation, Trp64Arg, in the β3-adrenergic receptor (β3AR). This mutation increases susceptibility to obesity and non-insulin dependent diabetes mellitus (NIDDM; type II diabetes). Additionally, the patent outlines methods of diagnosis and treatment for subjects at risk of developing these conditions. Another significant patent focuses on the susceptibility gene for obesity and type II diabetes mellitus, further emphasizing the importance of the Trp64Arg mutation in these diseases.
Career Highlights
Jesse Roth is affiliated with Johns Hopkins University, where she continues her research and innovation in the medical field. Her work has garnered attention for its potential impact on public health, particularly in addressing the obesity epidemic and diabetes management.
Collaborations
Roth collaborates with esteemed colleagues such as Jeremy D. Walston and Alan R. Shuldiner, contributing to a rich environment of research and innovation.
Conclusion
Jesse Roth's contributions to the understanding of obesity and diabetes through her innovative patents highlight her role as a leading inventor in the medical research community. Her work not only advances scientific knowledge but also holds promise for improving health outcomes for many individuals.